Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection (Q45860738)

17 December 2017

title

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

25 October 2022

1 reference

el-Amin D

6

1 reference

17 December 2017

K. M. Butler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

R. N. Husson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

F. M. Balis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

P. Brouwers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

J. Eddy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

D. el-Amin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

J. Gress

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

M. Hawkins

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

P. Jarosinski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

H. Moss

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670591

25 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

17 December 2017

17 January 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1670591

full work available at URL

25 October 2022

number of pages

8

1 reference

based on heuristic

inferred from page(s)

http://www.nejm.org/doi/pdf/10.1056/NEJM199101173240301

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

The New England Journal of Medicine

25 October 2022

published in

1 reference

17 December 2017

volume

324

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

137-144

1 reference

17 December 2017

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

25 October 2022

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis

25 October 2022

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex

25 October 2022

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

25 October 2022

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

25 October 2022

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

25 October 2022

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids

25 October 2022

16

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Aerosolized pentamidine and pancreatitis

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Studies of the outer membrane proteins of Branhamella catarrhalis

25 October 2022

18

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

25 October 2022

19

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

Lymphocyte subsets identified by monoclonal antibodies in healthy children

25 October 2022

20

1 reference

https://api.crossref.org/works/10.1056/NEJM199101173240301

25 October 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017